Managers

Catalyst Health Ventures seeks $100 mln for Fund IV

Catalyst Health Ventures targets $100 mln for fourth fund

Catalyst Health Ventures is seeking to raise $100 million for its fourth fund, according to an SEC filing. Braintree, Massachusetts-based Catalyst Health Ventures is an early-stage venture firm that invests in technology solutions within the health care and life science industries.

Synthego nets $110 mln Series C

Silicon Valley-based Synthego, a genome engineering innovation company, has raised $110 million in Series C financing. Founders Fund led the round with participation from return backers 8VC and Menlo Ventures.

Decoy Biosystems attracts funding from Mountain Pacific Venture Fund

San Diego-based Decoy Biosystems, a cancer immunotherapy company, has secured an undisclosed amount of funding. The investor was Mountain Pacific Venture Fund.

As unicorn financings increase, so does the use of structure

Stoke Therapeutics inks $90 mln Series B

Bedford, Massachusetts-based Stoke Therapeutics, a biotech firm, has raised $90 million in Series B financing. RTW Investments led the round with participation from other investors that included Apple Tree Partners, RA Capital Management, Cormorant Asset Management, Perceptive Advisors, funds managed by Janus Henderson Investors, Redmile Group, Sphera Funds Management and Alexandria Venture Investments.

IA Ventures seeks $160 mln, emphasizes passion as investment decision criteria

Stray Dog collects $23.7 mln for sophomore fund

Stray Dog Capital has raised $23.7 million for its second fund, according to an SEC filing. No target was listed on the document. Based in Leawood, Kansas, Stray Dog invests in early-stage businesses.

Qpex Biopharma nabs $33 mln Series A

Qpex Biopharma, a developer of antiobiotics, has raised $33 million in Series A financing. New Enterprise Associates led the round with participation from Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Draper Fund.

Raremark lands funding

London-based Raremark, a patient-data platform in rare disease, has raised 3 million pounds in funding. AlbionVC and Ananda Ventures led the round with participation from Oltre Venture and the Cass Entrepreneurship Fund.